Physiotherapy Theory and Practice · 2023 · 10 citations · 29 references
MedicinePhysical MedicineRehabilitation MedicineFalls PreventionMusculoskeletal RehabilitationRehabilitationBalance AssessmentFall RiskFear Of FallingGait EvaluationMobility AssessmentMultiple Sclerosis6-Minute Walk TestBalance Outcomes MeasurementMultiple Sclerosis MobilityWalkingWalking Capacity
Background Social participation levels of individuals with Multiple Sclerosis (iwMS) are lower than those of healthy individuals.Objective This study aimed to evaluate to which extent the walking capacity, balance, and fear of falling (FoF) affect the community integration levels of iwMS.Methods Thirty-nine iwMS were evaluated for their participation levels [The Community Integration Questionnaire (CIQ)], walking capacity [The Six-Minute Walk Test (6MWT)], balance [Kinesthetic Ability Trainer (SportKAT®)], and FoF [The Modified Falls Efficacy Scale (MFES)]. Correlation and regression analyses were performed to detect the effects of SportKAT®, 6MWT, and MFES on CIQ.Results CIQ scores were significantly correlated with 6MWT (p = .043) and MFES (p = .005) scores, while CIQ was not related with static (for two feet test p = .356, for right single-leg stance test p = .412, for left single-leg stance test p = .730) and dynamic balance (for clockwise test p = .097, for counterclockwise test p = .540) measured with the SportKAT®. It was found that CIQ could be predicted by 6MWT and MFES at the level of 16% and 25%, respectively.Conclusion FoF and walking capacity are associated with community integration in iwMS. Therefore, physiotherapy and rehabilitation programs of iwMS should be combined with treatment goals to increase community integration, balance, and gait and decrease the disability and FoF from an early stage. Comprehensive studies examining other factors that may impact participation in iwMS with different levels of disability are needed.
29
Rating neurologic impairment in multiple sclerosis
John F. Kurtzke · Neurology · 1983 · 14.9K citations
PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS.
B Ashworth · PubMed · 1964 · 1.5K citations
Medicine, Neurology, Pharmacology +10
Keith Hill, Jenny Schwarz, Aileen J. Kalogeropoulos et al. · Archives of Physical Medicine and Rehabilitation · 1996 · 540 citations